Papaverine-phentolamine-pge1 15 recalls
The FDA has published 2 recalls involving Papaverine-phentolamine-pge1 15 since 2019. The latest was reported on 17 Apr 2019. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2019
Last 12 months0reported
Class I00% of total
Ongoing0latest 17 Apr 2019
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why papaverine-phentolamine-pge1 15 is recalled
Companies
By year
All papaverine-phentolamine-pge1 15 recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Papaverine-phentolamine-PGE1 15-0.5MG-10MCG/ML Injectable recalled | Health Solutions Pharmacy Center | Sterility | OR |
| Drug | CLASS II | Papaverine-phentolamine-PGE1 15-0.25MG-6MCG/ML Injectable recalled | Health Solutions Pharmacy Center | Sterility | OR |
Should you stop taking Papaverine-phentolamine-pge1 15?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.